Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBIBP-CorV Coadministration with Influenza and Pneumococcal Vaccines in Hemodialysis Patients
NCT05480436Phase 4Unknown
- Sponsor
- China National Biotec Group
- Start
- Aug 2022
- Primary completion
- Jan 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by China National Biotec Group. Status: unknown.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05480436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05480436.